DE69119588D1 - Verwendung von ketorolac zur behandlung von periodontitis - Google Patents

Verwendung von ketorolac zur behandlung von periodontitis

Info

Publication number
DE69119588D1
DE69119588D1 DE69119588T DE69119588T DE69119588D1 DE 69119588 D1 DE69119588 D1 DE 69119588D1 DE 69119588 T DE69119588 T DE 69119588T DE 69119588 T DE69119588 T DE 69119588T DE 69119588 D1 DE69119588 D1 DE 69119588D1
Authority
DE
Germany
Prior art keywords
ketorolac
treatment
periodontitis
prevention
safe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119588T
Other languages
English (en)
Other versions
DE69119588T2 (de
Inventor
Gary Kelm
Harvey Pickrum
Matthew Doyle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of DE69119588D1 publication Critical patent/DE69119588D1/de
Application granted granted Critical
Publication of DE69119588T2 publication Critical patent/DE69119588T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69119588T 1990-03-16 1991-03-01 Verwendung von ketorolac zur behandlung von periodontitis Expired - Fee Related DE69119588T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49469790A 1990-03-16 1990-03-16
US65106191A 1991-02-08 1991-02-08
PCT/US1991/001441 WO1991013609A1 (en) 1990-03-16 1991-03-01 Use of ketorolac for treatment of periodontal disease

Publications (2)

Publication Number Publication Date
DE69119588D1 true DE69119588D1 (de) 1996-06-20
DE69119588T2 DE69119588T2 (de) 1996-11-21

Family

ID=27051510

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119588T Expired - Fee Related DE69119588T2 (de) 1990-03-16 1991-03-01 Verwendung von ketorolac zur behandlung von periodontitis

Country Status (14)

Country Link
EP (1) EP0519983B1 (de)
JP (1) JP3140050B2 (de)
AT (1) ATE137967T1 (de)
AU (1) AU661818B2 (de)
BR (1) BR9106166A (de)
CA (1) CA2077693C (de)
DE (1) DE69119588T2 (de)
DK (1) DK0519983T3 (de)
ES (1) ES2086536T3 (de)
GR (1) GR3019928T3 (de)
IE (1) IE910886A1 (de)
NZ (1) NZ237449A (de)
SG (1) SG54157A1 (de)
WO (1) WO1991013609A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
DE4300697C1 (de) * 1993-01-13 1994-05-19 Roemmers Sa Keterolac-Derivat mit wesentlich geringerer gastrointestinaler Reizung und Ulzeration
US5626838A (en) * 1995-03-13 1997-05-06 The Procter & Gamble Company Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx
US5807541A (en) * 1996-04-22 1998-09-15 Sepracor, Inc. NSAID/fluoride periodontal compositions and methods
BRPI0302736B8 (pt) 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
US7732478B2 (en) 2004-01-09 2010-06-08 The Trustees Of Columbia University In The City Of New York Methods for facilitating metabolic control

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607316A (nl) * 1975-07-04 1977-01-06 Gaba Ag Mond- en tandverzorgingsmiddelen.
US4919939A (en) * 1986-04-29 1990-04-24 Pharmetrix Corporation Periodontal disease treatment system
ZA886757B (en) * 1987-09-11 1990-05-30 Syntex Inc Preservative system for ophthalmics formulations
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease

Also Published As

Publication number Publication date
ES2086536T3 (es) 1996-07-01
GR3019928T3 (en) 1996-08-31
NZ237449A (en) 1996-10-28
CA2077693C (en) 1997-03-04
CA2077693A1 (en) 1991-09-17
SG54157A1 (en) 1998-11-16
JPH05505400A (ja) 1993-08-12
EP0519983A4 (en) 1993-03-10
ATE137967T1 (de) 1996-06-15
DE69119588T2 (de) 1996-11-21
EP0519983B1 (de) 1996-05-15
JP3140050B2 (ja) 2001-03-05
AU661818B2 (en) 1995-08-10
WO1991013609A1 (en) 1991-09-19
IE910886A1 (en) 1991-09-25
BR9106166A (pt) 1993-03-16
EP0519983A1 (de) 1992-12-30
DK0519983T3 (da) 1996-10-14
AU7472991A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
DE69621012T2 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
BR9105531A (pt) Composicao oral anticalculo e processo para tratar dentes
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
BR9106864A (pt) Composicoes de liberacao prolongada para o tratamento de doencas periodontais
FI880425A (fi) Antibakteriellinen plakkia ja hammaskiveä estävä oraalinen koostumus
DE69011560T2 (de) Oralmittel zur Behandlung von Überempfindlichkeit der Zähne.
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE139445T1 (de) Verwendung von zinkionen zur behandlung der periodontitis
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
FI97443C (fi) Hammasplakkia ja hammaskiveä estävä oraalinen koostumus
KR950702405A (ko) 구강 조성물(oral compositions)
DE69119588T2 (de) Verwendung von ketorolac zur behandlung von periodontitis
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE3867634D1 (de) Neue zahnaertztliche zubereitung und verfahren zur herstellung.
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
ATE142875T1 (de) Methode zur behandlung von haarausfall
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
SE8004592L (sv) Tandkrem
IT1164692B (it) Perfeziomanento nelle composizioni per la prevenzione della carie dentaria
KR960003712A (ko) 프로폴리스 함유 치약조성물
DE68914886D1 (de) Mittel zur Behandlung von Raynaud's Krankheit.
MY103310A (en) Oral composition
DE68901234D1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE TRUSTESS OF COLUMBIA UNIVERSITY IN THE CITY OF

8339 Ceased/non-payment of the annual fee